Postoperative recurrence in non-small cell lung cancer (NSCLC) reduces the life expectancy of patients. In this retrospective study, we investigated the prognostic factors in patients with postoperative brain metastases from surgical resected non-small cell lung cancer (NSCLC).We conducted a ...
many with AD, who are expected to have age-associated neuron loss. This may enhance correlations between cell composition and methylation PCs that were not otherwise apparent in training data capturing the entire lifespan. Third, the proportion of neurons in test data, unlike training...
Postoperative recurrence in non-small cell lung cancer (NSCLC) reduces the life expectancy of patients. In this retrospective study, we investigated the prognostic factors in patients with postoperative brain metastases from surgical resected non-small cell lung cancer (NSCLC). Methods We conducted a ...
The disease is lethal, with an average life expectancy of approximately 5 years after diagnosis. Currently, only two drugs are used to treat ALS, although neither prevents disease progression [39]. Research is being conducted into new treatment approaches, such as gene editing and stem cell ...
life score of a cohort of non-CSN cancer group of patients with a cohort of patients with high-grade glioma (HGG) [7]. For the scoring, as previously validated, one point is given for each indicator of aggressiveness in the last 30 days of life: ≥2 emergency room visits, ≥2 ...
The role of microRNA-338-3p in cancer: Growth, invasion, chemoresistance, and mediators. Life Sci. 2021, 268, 119005. [Google Scholar] [CrossRef] Catalanotto, C.; Cogoni, C.; Zardo, G. MicroRNA in control of gene expression: An overview of nuclear functions. Int. J. Mol. Sci. ...
Overexpression of CK2 leads to several pathological conditions, ranging from cardiovascular pathologies and cancer progression to infectious diseases and neurodegeneration. CK2 activity increases due to the presence of Aβ peptide and, thus, may accelerate τ phosphorylation. Besides CK2's role in AD ...